SCHEMBL9457380

SCHEMBL9457380

CCCCCCCCCCCC(CC(=O)O)OC1CCCCO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 4/20 0.41
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
MMP2 P08253 5/20 0.36
MMP3 P08254 5/20 0.36
MMP1 P03956 3/20 0.36
MMP7 P09237 1/20 0.36
MAPK1 P28482 3/20 0.36
CYP1A2 P05177 2/20 0.36
GMNN O75496 2/20 0.36
LMNA P02545 2/20 0.36
HSP90AA1 P07900 2/20 0.36
MAPT P10636 2/20 0.36
BLM P54132 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
NR1H4 Q96RI1 2/20 0.36
TP53 P04637 1/20 0.36
CYP2C9 P11712 1/20 0.36
TSHR P16473 1/20 0.36
HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9457371 1.00 GPR84 (0.41) GPR84MEN1KMT2AMMP2MMP3
SCHEMBL9457368 1.00 GPR84 (0.41) GPR84MEN1KMT2AMMP2MMP3
SCHEMBL9457193 1.00 GPR84 (0.41) GPR84MEN1KMT2AMMP2MMP3
SCHEMBL9649923 1.00 GPR84 (0.41) GPR84MEN1KMT2AMMP2MMP3
SCHEMBL30861816 0.95 MEN1 (0.36) GPR84MEN1KMT2AMMP1MMP7
SCHEMBL9457388 0.93 FFAR1 (0.39) KMT2AMMP2CYP1A2GMNNLMNA
SCHEMBL9457366 0.93 FFAR1 (0.39) KMT2AMMP2CYP1A2GMNNLMNA
SCHEMBL9457391 0.93 FFAR1 (0.39) KMT2AMMP2CYP1A2GMNNLMNA
SCHEMBL9457394 0.93 FFAR1 (0.39) KMT2AMMP2CYP1A2GMNNLMNA
SCHEMBL9457402 0.93 FFAR1 (0.39) KMT2AMMP2CYP1A2GMNNLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5246960-A Used to treat obesity, hyperlipaemia, atherosclerosis and arteriosclerosis HOFFMANN-LA ROCHE INC. (US) 1993-09-21 US disclosed
US-5175186-A Inhibits pancreas lepase and useful agent in treatment of obesity, hyperlipemia, atherosclerosis and arteriosclerosis HOFFMANN-LA ROCHE INC. (US) 1992-12-29 US disclosed
US-4983746-A Oxetanones and process for their production HOFFMANN-LA ROCHE INC. (US) 1991-01-08 US disclosed
US-4931463-A PANCREAS LIPASE INHIBITORS HOFFMANN-LA ROCHE INC. (US) 1990-06-05 US disclosed